Granules India, incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 7009.56 Crore) operating in Pharmaceuticals sector.

Our supply chains have been quite stable for a long time even though we still continue to buy some products from China.

Money managers increased the weights of banks, technology, oil & gas, capital goods, and utilities, while moderating weights in consumer, NBFCs, autos, healthcare, retail, chemicals, telecom, consumer durables, and textiles, shows a report by Motilal Oswal.

“The stock price started its up move from Rs 84 (July 2019). The stock made a high of Rs 438 in Dec 2020 accompanied by Higher Bottoms & Top formations,” Bharat Gala, President - Technical Research, Ventura Securities Ltd, said.

Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.

Rupak De, Senior Technical Analyst at LKP Securities, said: "Nifty remained volatile during the day before closing on a flat note. On the daily chart, the index has been consolidating for the last few days. However, it has sustained above the crucial moving average on the daily timeframe confirming the uptrend. On the higher end, the index may move towards 17,950. On the lower end, support is visible at 17,650/17,550."

The company said 51% of its revenue came from finished dosages, which is its biggest business. Active pharmaceuticals ingredients and pharmaceutical formulation intermediates contributed 29% and 20%, respectively, to its revenue.

The Indian market is opened lower on Thursday tracking muted global cues.The S&P BSE Sensex slipeed over 200 points while Nifty50 declined below 17,500 levels in opening trade.We have collated stocks from various experts for traders who have a short-term trading horizon:

The S&P BSE Sensex rose over 500 points on Tuesday while Nifty50 closed with gains of over 1 per cent in the previous trading session.

The stock saw a vertical move to Rs 330 in August and post that it started consolidating. The recent price action helped the stock to break out of the consolidation range on daily charts since August and from an inverse head and shoulder pattern on the weekly charts.

The counter has witnessed a Channel breakout on the weekly chart and the stock is in the formation of higher highs and higher lows on the daily chart for the last four consecutive days.

The Adani family said it has completed the acquisition of Ambuja Cements & ACC and has become country's second largest cement player.

Granules is a large-scale vertically integrated company that manufactures API, intermediates and finished dosages and has seven manufacturing facilities along with B2B & B2C marketing and distribution.

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8005.63 Crore) operating in Pharmaceuticals sector.

United Spirits, Hero MotoCorp, EID Parry (India), Paushak and Unichem Laboratories will have their annual general meetings (AGM) today.The board of eClerx Services will meet today to consider a bonus issue while the board of JBM Auto and Capacit'e Infraprojects will meet today to consider a preferential issue.

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 7309.97 Crore) operating in Pharmaceuticals sector.

Despite the rebound, we feel the market has not reached its bottom, since price patterns on the Nifty50 show that the uptrend has been significantly harmed, said Yesha Shah, Head of Equity Research, Samco Securities.

NSE:GRANULES first granules took support from channel and now giving breakout with volume. one can go for swing but here stop loss is quite big so go with less quantity. ******whatever charts or levels sharing here or on any other platforms are just for educational purpose only, Not A Recommendation To Buy Or Sell. Please do your own analysis before taking any trade on them. We are not SEBI registered.

The board of Cigniti Technologies will consider and approve a proposal for buyback of fully paid-up equity shares of the company today.

Nifty50 on Tuesday formed a large bullish candle on the daily chart after making what looked like a Bullish Harami candle in the previous day, sending signs of reversal. With this, the index has chalked out a new range after offering strong support at the lower end of the 15,750-16,150 range in the last few sessions.

Selling by foreign institutional investors have kept the market under pressure. As per latest data available, they have already withdrawn Rs 25,216 crore from equities so far in May. Going by the trend, this may continue going forward as well.

The Nifty Pharma index closed 1.48 per cent down at 12596.3.